Throughout the last two decades, BioCrossroads has encouraged growth within Indiana’s life sciences industry through both direct and indirect activities that have advanced Indiana’s standing as a national life sciences leader. There is a lot to reflect on as an organization and as an industry, and a bright future to look forward to thanks to the dedication, connections and collaboration of this unique sector.

During the 20th CELLebration conference, we heard from many of the companies and individuals who have been impacted by BioCrossroads and life sciences community, including Cook Medical, SonarMed, Indiana Clinical and Translational Sciences Institute, Indy Hub, Indiana Health Information Exchange and more. We also recognized Nora Doherty as the Watanabe Life Sciences Champion of the Year. If you missed it, you can see each presentation, panel and discussion below.

Agenda

WELCOME & TALENT

Patty Martin, President and CEO, BioCrossroads
David Johnson, President and CEO, Central Indiana Corporate Partnership
Dan Peterson, Vice President, Government and Industry Affairs, Cook Medical

Cook Medical’s Unique Talent Programs: Putting People First
Pete Yonkman, President and CEO, Cook Medical
Juanita Easterling, General Manager, Goodwill Commercial Service
Chantel Poston, Mission Coach, Goodwill Commercial Service

Roche Diagnostics: Importance of Diagnostics to Patients and Employees
Christine Krull, Program Director, Roche Diagnostics
Michael Santa Maria, Product Owner, Field Service Global Customer Support, Roche Diagnostics

INNOVATION

How has innovation changed over the last 20 years? How has Purdue contributed to that? What’s on the horizon?
Brooke Beier, PhD, Senior Vice President, Commercialization, Purdue Research Park

A 15-year Start-up Story that Saves Infant Lives
Laura Lyons, former VP Clinical, Quality & Regulatory Affairs, Sonarmed

Changing Diabetes Outcomes Through Innovation
Julie Moyers, PhD, Associate Vice President, Eli Lilly and Company
Kelly Frankel, Associate Vice President and Brand Leader, US Diabetes, Eli Lilly and Company

COLLABORATION 1

BioCrossroads’ opportunistic enterprises impact on people – Indiana Health Information Exchange, Indiana Biosciences Research Institute / 16 Tech, Indy Hub

IHIE
John Kansky, President and CEO, Indiana Health Information Exchange
Varon Cantrell, CMIO, HealthNet
Tom Arkins, Chief of IT and Informatics, Indianapolis EMS

Indiana Biosciences Research Institute/16 Tech
Thakshila Liyanage, PhD, Founder and President, EarlyisGood.com

Indy Hub
Al Carroll, Executive Director, Indy Hub
Alex Simonton, Director of Strategy, IU Health Foundation

COLLABORATION 2

Indiana research institution partnerships that have changed lives

Monon Collaborative
Indiana Clinical and Translational Research Institute
Sharon Moe, MD, Co-Director, Indiana Clinical and Translational Sciences Institute at Indiana University
Sarah Wiehe, MD, Co-Director, Indiana Clinical and Translational Sciences Institute at Indiana University

AnalytiXIN
University of Notre Dame
Nitesh Chawla, PhD, Founding Director, Lucy Family Institute for Data and Society
Valya Kuskova, PhD, Managing Director, Notre Dame AnalytiXIN site at Indianapolis
Antonio Karam, Sophomore computer science major

FINAL REMARKS

Dan Peterson, Vice President, Government and Industry Affairs, Cook Medical

SPONSORS

PRESENTING SPONSORS

LEARN MORE
LEARN MORE

GOLD SPONSOR

LEARN MORE

BRONZE SPONSORS

LEARN MORE
LEARN MORE

EVENT SPONSORS

LEARN MORE
LEARN MORE
LEARN MORE
LEARN MORE
LEARN MORE